• 170859
在此页面上
BCG009, a Fully Human Anti-IGF-1R Antibody, as a Second-Generation Therapeutic for the Indication of Thyroid Eye Disease (TED)
A bispecific anti-PD-1 and PD-L1 antibody induces PD-1 cleavage and provides enhanced anti-tumor activity
The establishment and application of CD3E humanized mice in immunotherapy